close

Enter

Log in using OpenID

Plasminogen Activator Inhibitor Market - Size, Share, Outlook, and Analysis 2018–2026

embed
Increasing number of pipeline drugs for treating wounds and thrombosis can propel the growth of plasminogen activator inhibitor market
Plasminogen Activator Inhibitor Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Plasminogen Activator Inhibitor Market – Overview
Plasminogen activator inhibitors also known as Serpin E1 is a protein present in the body whose elevated levels
are responsible for thrombosis and atherosclerosis. (Plasminogen Activator Inhibitor Type 1 (PAI-1) is mainly
secreted by the endothelium (cells lining blood vessels), and adipose tissues whereas Plasminogen Activator
Inhibitor Type 2 (PAI-2) is secreted by the placenta and only present in significant amounts during pregnancy.
PAI-1 plays an important role in aging and is secreted in senescent cells. Complete plasminogen activator
inhibitor 1 deficiency (complete PAI-1 deficiency) is a disorder that causes abnormal bleeding.
Increasing number of pipeline drugs for treating wounds and thrombosis can propel the growth of plasminogen
activator inhibitor market. For instance, Denver Health and Hospital Authority is undergoing clinical phase II
study for treating thromboembolism and wounds by aspirin and rosuvastatin. The study aims to measure PAI-1
and tissue plasminogen activator inhibitor levels in the plasma after drug treatment. The study started in February
2017 and is estimated to complete in December 2021.
REPORT DESCRIPTION
Plasminogen Activator Inhibitor Market Taxonomy:
By Product Type
Plasminogen Activator Inhibitor Type 1 (PAI-1)
Plasminogen Activator Inhibitor Type 2 (PAI-2)
By Application
Fibrinolysis
Cardiac Fibrosis
Post-operative Wound Hematomas
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2288
REPORT DESCRIPTION
Plasminogen Activator Inhibitor Market – Key Players





Bayer AG
SteadyMed Ltd
GlaxoSmithKline plc
Pfizer Inc., Abcam plc
ARUP Laboratories
Increasing product recall due to variations in the PAI kits is responsible for uneven results which is
affecting the growth of plasminogen activator inhibitor market. For instance, in July 2016, U.S. Food and
Drug Administration (USFDA) recalled IMUBIND Plasma PAI-1 Enzyme Linked Immunosorbant Assay
(ELISA) kits manufactured by American Diagnostica, Inc. The recall was initiated due to unacceptable
microwell to microwell variation in the section of the ELISA plates that is typically used for the calibrators.
This product affected the reproducibility of the results which can restrain the market.
Read More @
https://www.coherentmarketinsights.com/ongoing-insight/plasminogen-activator-inhibitor-market-2288
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent
Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE




BIOTECHNOLOGY
CLINICAL
DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL
IMAGING
PHARMACEUTICA
L
OUR
Global
Leading Equipment and System Manufacturers
CLIENTS
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
 Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
CONSUL
T
PROJECT
S
COUNT
RY
ANALYS
IS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
TECHNOLOG
Y SNIPPETS
COMPETITIV
E
ASSESSMEN
T
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
1/--pages
Report inappropriate content